The NHS-Galleri trial: What to expect in 2026 from the world’s first randomized controlled trial of a Multi-Cancer Early Detection test, Galleri®
As the multi-cancer early detection (MCED) field evolves, we and others have asserted that it is essential – in order for individuals to have confidence in a test – that it must have demonstrated…
Read the full articleYou might also wanna read
Galleri Blood Test Shows Promise in Detecting 50 Types of Cancer in Large Clinical Trial
The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.
Untitled
The news at 22:29:48 is: NHS trial of blood test offers 'genuine hope' for people with some cancers, A blood test designed to detect multipl
Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A Mixed Cluster-Individual RCT
Conditions : Breast Neoplasms; Early Detection of Cancer Interventions : Procedure: Standardized Breast Ultrasound Screening Sponsors : The
A Multicenter Randomized Open-Label Trial Evaluating MRD-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.
Conditions : NSCLC (Advanced Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Cancer); NSCLC (Non-small Cell Lung Carcinoma); NSCLC;
Los nuevos diagnósticos de cáncer no aumentaron como se anticipaba después de la pandemia
Aunque los nuevos diagnósticos de cáncer volvieron en gran parte a los niveles prepandémicos en 2021, no reflejan los diagnósticos ausentes

GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment
CHICAGO, Ill. and ROCHESTER, Minn. — GE HealthCare and Mayo Clinic today announced the MI-BET (Molecular Imaging Biomarker-Based End of Ther

Comments
Sign in to join the conversation.
No comments yet. Be the first.